Interview with DBS Systems, the revolution in blood collection
DBS System is a medtech startup founded in December 2010 and…
DBS System mentioned in the press release of "La Côte" of March 19th
Link to Article Source: http://goo.gl/66W6kh
Selected Companies for the Entente Life Sciences Investment Forum
The partners of the ENTENTE-project together with the European…
Medtech. La start-up DBS System a développé une plaque microfluidique....
L’avance technologique reconnueMedtech.
La start-up DBS…
DBS System révolutionne et simplifie les prises de sang
DBS System révolutionne et simplifie les prises de sang
Bientôt,…
DBS System is selected by the Alpine Venture Forum committee to present its innovative micro-sampling solution.
The event will be a unique occasion for the most promising…
DISCLAIMER
HemaXis DB is a FDA Class 1 medical device. HemaXis DX is in development and for research purposes only. Use of HemaXis devices in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with local regulatory requirements.
By using this website you are agreeing to our Terms and Conditions.
CONTACT
DBS System SA
Rte des Avouillons 6
CH-1196 Gland
Switzerland
Tel: +41 (0) 78 624 70 15
Email: info@dbs-system.ch
LEGAL DOCUMENTS
Read Our Privacy Policy
Read Our General Terms and Conditions of Sale
Read Our Shipping Information